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Abstract 
Uterine leiomyomata are the commonest neoplasms of 
female reproductive tract. On an average there are six to 
seven fibroids in the affected uterus. These neoplasms 
may lead to symptoms like menorrhagia, dysmenorrhea, 
pressure effects, urinary frequency, pelvic pain, infertility 
and pelvic mass. Here we present a case report of 34 years 
old nulliparous women having an unusual number (48) of 
fibroids. As she was nulliparous and wanted to conceive, 
her uterus was conserved and all the fibroids were 
surgically removed. 




Uterine leiomyomata or fibroids are the commonest 
neoplasms of the female reproductive tract and effect 20-
40% of the premenopausal women.1 Although benign, these 
neoplasms lead to symptoms like menorrhagia, 
dysmenorrhea, pressure effects, urinary frequency, pelvic 
pain, infertility and pelvic mass.2 Uterine leiomyomata are 
present in three different locations in the uterine wall and 
are termed according to their site. Sub-serosal leiomyoma 
projects outwards from the uterine surface: intra-mural 
leiomyoma lie within the wall of the uterus while Sub-
mucosal project into the uterine cavity.3 Over 75% of 
reproductive age females have on an average affected uterus 
containing six to seven fibroids.4 The size and location of 
fibroid within the uterus may lead to infertility and cause 
pregnancy related complications.5 A case report is being 
presented in which the number of uterine leiomyomata were 
unusual and forty eight fibroids were removed per-
operatively with conservation of uterus. 
 
Case Report 
A thirty four years old nulliparous women having 
complaints of menorrhagia and pressure symptoms for the 
past six years presented in the private clinic of one of the 
authors for advise and treatment. The patient was examined 
and routine investigations were carried out. Her 
ultrasonography revealed multiple uterine fibroids. These 
findings and available treatment options were explained and 
discussed with the patient. As she wanted to conceive, most 
suitable treatment option was to remove the fibroids and 
conserve the uterus. She was operated upon and 
peroperative findings included enlarged, distorted uterus 
containing multiple nodules of variable sizes. A total 
number of forty eight fibroids were carefully identified and 
surgically removed. Specimen containing all the fibroids 
was sent for histopathological examination in formalin 
fixative. Gross examination findings of the specimen 
confirmed a total number of forty eight fibroids of variable 
sizes collectively weighing 2.1 kg. (Fig.1) The largest 
fibroid was 12 cms in diameter and smallest one measured 
0.8 cms in diameter. Cut surfaces showed a characteristic 
whorled pattern and in some of the fibroids there were focal 
degenerative changes. Histopathological examination 
revealed features of benign leiomyomata and no evidence of 








Uterine leiomyomas can occur singly but are often multiple 
and show variation in sizes. They are more frequently 
present in women of African origin than women of other 
ethnic groups. African American women are reported to 
have an earlier age of uterine leiomyoma diagnosis. These 
women have larger and more abundant tumors, more severe 
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symptoms and higher rates of hysterectomy. Risk factors for 
leiomyomas include early age of menarche, nulliparity, oral 
contraceptive use and obesity.4 
The list of treatment options for women having leiomyomas 
is expanding rapidly. New procedures have been introduced 
other than hysterectomy and myomectomy, such as Uterine 
Artery Embolization (UAE) and High intensity focused 
ultrasound (HIFU). These procedures are in demand by 
women who want minimized recovery time and preservation 
of their uterus.6 The type and timing of intervention should 
be individualized, based upon factors such as size of the 
fibroid, its location, severity of symptoms, patient age, 
reproductive plans and obstetrical history.7  
Those women who are asymptomatic should be initially 
observed without any treatment. Symptomatic women who 
desire fertility preservation should have non-surgical 
treatment first and then myomectomy. Symptomatic women 
who do not desire future fertility but wish to preserve the 
uterus can have non-surgical treatment or myomectomy, 
myolysis or uterine artery embolization. Women with 
pregnancy complications should have myomectomy 
procedure. Whereas women having severe symptoms and 
who desire definitive treatment should have hysterectomy 
done.8 Hysteroscopic myomectomy can be considered as 
first line surgical conservative therapy for management of 
intracavitary myoma. 
With a newer understanding of modern surgical techniques 
more tailored options are available for the patients. In 
nulliparous women myomectomy followed by GnRH 
analogs for 3 months seems to be the best surgical approach 
for multiple fibroids. Asymptomatic fibroids may be 
managed by reassurance and careful follow-up. Medical 
therapy should be tried as first line of treatment for 
symptomatic myomas while surgical therapy should be 
reserved only for appropriate indications. Preoperative 
gonadotrophin hormone releasing hormone treatment 
decreases the size and vascularity of myoma, but may render 
the capsule more fibrous and difficult to resect. Uterine 
artery embolization is an effective alternative treatment for 
women having large symptomatic myomas and are poor risk 
or wish to avoid major surgery.9 
The mechanism that initiates uterine fibroid growth and 
pathogenesis is not completely understood. There is still no 
definitive evidence why fibroids develop and why do they 
grow. Risk factors attributed to development of fibroids 
include earlier menopause, fewer births after age 24, alcohol 
intake, sedentary life style, prenatal DES exposure and 
higher circulating levels of LH are also linked to fibroids.10  
Researchers are trying to find out the causative gene 
interaction, enzymes responsible for estrogen biosynthesis 
produced locally and mechanism responsible for cell cycle 
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